Literature DB >> 15480040

Hyperacute extensive middle cerebral artery territory infarcts. Role of computed tomography in predicting outcome.

Wynnie Wai-Man Lam1, Thomas Wai-Hong Leung, Winnie Chiu-Wing Chu, Deacons Tai-Kong Yeung, Lawrence Ka-Sing Wong.   

Abstract

OBJECTIVE: To assess the prognostic value of computed tomography (CT) in hyperacute middle cerebral artery (MCA) infarcts.
METHODS: The CT features, total CT score, and National Institutes of Health Stroke Scale (NIHSS) score were correlated with the 30-day mortality in 16 patients with a hyperacute MCA infarct.
RESULTS: Admission NIHSS scores were significantly lower in the survival group (P = 0.016). The extent of infarct, attenuation of corticomedullary differentiation, and total CT score were associated with 30-day mortality (P < 0.05). In prediction of mortality, extent of an infarct > 67% gave sensitivity, specificity, positive predictive value, and negative predictive value rates of 86%, 100%, 100%, and 90%, respectively. Attenuation of corticomedullary differentiation gave sensitivity, specificity, positive predictive value, and negative predictive value rates of 86%, 89%, 86%, and 89%, respectively. An NIHSS score > 28 gave sensitivity, specificity, positive predictive value, and negative predictive value rates of 86%, 67%, 67%, and 86%, respectively. A CT score > 4 gave sensitivity, specificity, positive predictive value, and negative predictive value rates of 86%, 78%, 75%, and 88%, respectively.
CONCLUSIONS: Computed tomography features and the admission NIHSS score are important predictors of survival in hyperacute extensive MCA infarcts.

Entities:  

Mesh:

Year:  2004        PMID: 15480040     DOI: 10.1097/01.rct.0000136456.25506.c3

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  1 in total

1.  Toward patient-tailored perfusion thresholds for prediction of stroke outcome.

Authors:  A Eilaghi; C D d'Esterre; T Y Lee; R Jakubovic; J Brooks; R T-K Liu; L Zhang; R H Swartz; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2013-10-10       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.